Chapter 6: Pediatric Pharmacology & Safe Medication Use

Pharmacokinetic processes—absorption, distribution, metabolism, and excretion—are significantly influenced by a child's age and organ maturity. For example, neonates exhibit alkaline gastric pH and unpredictable intestinal motility, which affects oral drug absorption, while their thinner skin increases the risk of toxicity from topical treatments. Distribution is altered by a higher percentage of body water and reduced protein-binding sites, often necessitating adjusted dosages to avoid high levels of unbound, toxic drugs. Furthermore, immature blood-brain barriers and reduced hepatic and renal functions, such as a lower glomerular filtration rate, demand vigilant monitoring of drug levels. The text emphasizes that most pediatric dosing is determined by weight in kilograms or body surface area rather than adult standards. Nursing practice in this area centers on the principle of atraumatic care, which seeks to minimize psychological and physical distress through family-centered collaboration and age-appropriate communication strategies. This includes using oral syringes for precise measurement and avoiding invasive procedures when possible. As patients transition into adolescence, care must adapt to rapid physical growth, hormonal shifts, and the cognitive shift from concrete to abstract reasoning, which influences how teens understand and adhere to medication regimens. Effective patient and family education remains a cornerstone of safety, particularly regarding the risks of over-the-counter medications and the importance of accurate measurement to prevent administration errors. By integrating developmental theory with clinical vigilance, healthcare providers can navigate the complexities of treating this vulnerable population.